このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

癌 に 関する 骨 の 痛み の 治療 に 関し て,通常 の 薬 の ほか に 見る

  • 01 The University of Kansas School of Pharmacy, Wichita Campus, Wichita, Kansas.

|

|

まとめ

この要約は機械生成です。

標準的な治療法が適切でない場合,代替薬は癌に関連する骨の痛みを緩和する可能性があります. これらの選択肢の有効性と最適な使用を確認するには,さらなる研究が必要である.

科学分野

  • 腫瘍学
  • 痛みの管理
  • 薬理学について

背景

  • 癌に起因する骨の痛みは 高齢者の間でよく見られる 衰弱する問題です
  • NSAIDやオピオイドのような標準的な治療は,患者の併発症や副作用によって制限されることがあります.
  • この集団にとって 痛みの管理のための 代替戦略を探求することが 極めて重要です

研究 の 目的

  • 高齢者の癌に関連する骨の痛みに対する代替薬の検討
  • 標準的な治療法と比較して副作用を最小限に抑える治療法を特定する.
  • 非伝統的疼痛管理の有効性を評価する.

主な方法

  • キーワード"骨の痛み"と"薬"を使ってPubMedで文献検索を行った.
  • 2004年から2024年の間に英語で出版された癌による骨の痛みに関連した論文のみをフィルタリングした.
  • データ分析のために12の選択された論文を合成した.

主要な成果

  • ビスホスフォネート,デノスマブ,抗ヒスタミン剤,抗うつ剤,抗発作剤,コルチコステロイド,ケタミン,カンナビノイドを含むいくつかの代替治療法が特定されました.
  • ビスフォスフォネートとデノスマブは,治療よりも骨の痛みの予防においてより有望であることが示されました.
  • 抗うつ薬と抗薬は神経疾患の骨の痛みの成分に有益でした.

結論

  • 代替治療は,標準的な薬剤を使用できないまたは反応しない患者の癌に関連する骨の痛みの管理に希望を示しています.
  • これらの代替治療の有効性と最適な適用を確立するためにさらなる研究が不可欠です.
  • 異なる薬に対する反応が異なるため,個別化された治療方法が必要である.

関連する概念動画

Cancer Therapies 02:49

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies 02:57

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers 02:56

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Blood and Nerve Supply to the Bones 01:29

11.8K

Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...

Combination Therapies and Personalized Medicine 02:50

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy 01:27

659

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.